CG Stock Recent News

CG's fourth-quarter 2024 results benefit from growth in segment fee revenues. Yet, an increase in expenses acts as a headwind.

The Carlyle Group Inc. (NASDAQ:CG ) Q4 2024 Earnings Conference Call February 11, 2025 8:30 AM ET Company Participants Daniel Harris - Head of Investor Relations Harvey Schwartz - Chief Executive Officer John Redett - Chief Financial Officer and Head of Corporate Strategy Conference Call Participants Alexander Blostein - Goldman Sachs Brendan O'Brien - Wolfe Research Patrick Davitt - Autonomous Research Brian Bedell - Deutsche Bank Brian McKenna - Citizens JMP Glenn Schorr - Evercore ISI Benjamin Budish - Barclays Daniel Fannon - Jefferies William Katz - TD Cowen Kenneth Worthington - JPMorgan Michael Cyprus - Morgan Stanley Kyle Voigt - KBW Michael Brown - Wells Fargo Operator Hello everyone, and welcome to The Carlyle Group Fourth Quarter 2024 Earnings. At this time, all participants are in a listen-only mode.

Carlyle Group Inc.'s stock fell 5% on Tuesday after the private-equity firm signaled a slowdown in its fee-related earnings growth in 2025, as it leans on its private-credit arm to increase its profit.

Although the revenue and EPS for Carlyle (CG) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Carlyle (CG), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2024.

Acentra Health welcomes noted public sector health leaders Calder Lynch and Jami Snyder to its healthcare advisory board; appoints Julie Boughn as chair.

NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Carlyle Credit Income Fund (the “Fund”) (NYSE: CCIF), an externally managed closed-end fund focused on investing in primarily equity and junior debt tranches of collateralized loan obligations, has entered into a Purchase Agreement with certain institutional investors for the purchase and sale of approximately 20,000 shares of the Fund's 7.50% Series C Convertible Preferred Shares due January 2030 (the “Convertible Preferred Shares”), liquidation preference $1,000.00 per share. The Fund expects to receive net proceeds (before expenses) from the sale of the Convertible Preferred Shares of approximately $18.6 million. The offering is expected to close on or about January 31, 2025, subject to the satisfaction of customary closing conditions.

LOS ANGELES , Jan. 29, 2025 /PRNewswire/ -- Entertainment 360, one of the world's premier talent management companies, announced today that it would be receiving an investment from global investment firm Carlyle. The transaction marks the first time in Entertainment 360's 22-year history that the company has received outside funding.

NEW YORK, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Carlyle Credit Income Fund (“we,” “us,” “our,” “CCIF” or the “Fund”) (NYSE: CCIF) announced today that it will release financial results after market close on Wednesday, February 26, 2025, for its first quarter of 2025. CCIF will host a conference call at 10:00 a.m. EDT on Thursday, February 27, 2025, to discuss the results.

MCLEAN, Va., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, announced it has appointed Ezmeralda Sager as Executive Vice President and Chief Transformation Officer (CTO), effective January 6, 2025.